THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD)

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM NEW
Total 13F shares
24,236,562
Share change
-598,188
Total reported value
$11,146,000
Price per share
$0.46
Number of holders
63
Value change
-$292,581
Number of buys
25
Number of sells
28

Institutional Holders of THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) as of Q1 2016

As of 31 Mar 2016, THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,236,562 shares. The largest 10 holders included Sio Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, Cormorant Asset Management, LLC, SABBY MANAGEMENT, LLC, and STATE STREET CORP. This page lists 63 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.